Swine flu news round-up

NewsGuard 100/100 Score

The German government is looking to sell over 2 million leftover doses of the H1N1 (swine flu) vaccine, the country's health minister said Monday, Agence France-Presse reports. "A health ministry senior official in the state of Thuringia, Hartmut Schubert, said that the vaccines could even be donated and that there had been requests from Afghanistan and Eastern European countries including Ukraine," the news service adds (12/7).

In related news, "South Korea's [P]resident [Lee Myung-bak] offered Tuesday to send swine flu medication to North Korea amid reports that the virus killed dozens of people and is spreading fast in its impoverished communist neighbor," the Associated Press/New York Times reports. According to a report from the President's office, Lee asked his Cabinet to look into the reports of the H1N1 outbreaks in the North and examine ways to send supplies to the North.

''It would be good if emergency aid is provided as there are concerns that swine flu could spread rapidly,'' Lee told the Cabinet meeting, according to the statement from the President's office (12/7).

The AP also reports that Israel is treating patients suspected to have H1N1 from Gaza in hopes of containing the virus: "The move is a rare loosening of the tight blockade Israel imposed on Gaza after Hamas militants seized the coastal area in June 2007. Israel usually only allows patients with life-threatening conditions into Israel" (12/8). According to the Jerusalem Post, H1N1 has been confirmed in 1,250 Palestinians in the West Bank, but has not been linked to any deaths; in Israel, the virus has infected 8,500, killing 67 (Katz, 12/8).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers develop promising recombinant flu vaccine using nanoliposome technology